Skip to content
FDAFood

Nalpac Issues Voluntary Nationwide Recall of DTF Sexual Chocolate Due to the Presence of the Pharmaceutical Ingredient’s Sildenafil and Tadalafil

FDA recall n-nalpac-issues-voluntary-nationwide-recall-dtf-sexual-chocolate-due-presence-phar ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

What the agency says to do

FDA’s record gives no instruction for consumers.

Note from Recalls Watch, not agency text

Why it was recalled

Undeclared Sildenafil and Tadalafil
Text from FDA, unedited.

The recalled product

FOR IMMEDIATE RELEASE – Date – Ferndale, Michigan. Nalpac is voluntarily recalling DTF Sexual Chocolate it purchased and resold. The products have been found to contain sildenafil and tadalafil.
Text from FDA, unedited.

Company announcement, as FDA publishes it

FOR IMMEDIATE RELEASE – Date – Ferndale, Michigan. Nalpac is voluntarily recalling DTF Sexual Chocolate it purchased and resold. The products have been found to contain sildenafil and tadalafil. Nalpac is not the manufacturer of this product.

Sildenafil and tadalafil are the active ingredients in the FDA-approved prescription drugs Viagra and Cialis, respectively, used to treat erectile dysfunction. FDA approval of Viagra and Cialis is restricted to use under the supervision of a licensed health care professional. These undeclared ingredients could interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels for those individuals who use prescriptions drugs which contain nitrates. Nalpac has not received any reports of adverse events related to this recall.

The recalled product is packaged in cases containing 20 retail units. The product can be identified by UPC 757817783069 on the product label. The product was available for purchase in adult retail stores and through shopsexology.com and royalsins.com. Please find the product label below:

Nalpac is not the Manufacturer of these products but is voluntarily recalling the product, notifying its customers by email and is arranging for return of all recalled products. Consumers and retailers that have the recalled product should stop using or selling products and return to the place of purchase or discard immediately.

Consumers with questions regarding this recall can contact Nalpac by telephone at 248-541-1140 or by email at sales@nalpac.com Monday to Friday from 8:00 am to 4:30 pm eastern. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Complete and submit the report:

Online: www.fda.gov/medwatch/report.htm

Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Text from FDA (the company’s words), unedited.
  • DTF Sexual Chocolate Chocolate

Source

Issued by
U.S. Food and Drug Administration
Firm
Nalpac

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Month: April 2026, Week 2026-W15. Browse more food recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

FDA states: “Undeclared Sildenafil and Tadalafil”

What should I do if I have this product?

FDA’s record gives no instruction for consumers. The official report is linked on this page.

Which products are included?

FDA states: “FOR IMMEDIATE RELEASE – Date – Ferndale, Michigan. Nalpac is voluntarily recalling DTF Sexual Chocolate it purchased and resold. The products have been found to contain sildenafil and tadalafil.”

When was this recall published?

FDA published this company announcement on April 6, 2026.